Analysis of clinical characteristics of mesalazine-induced cardiotoxicity

Analysis of clinical characteristics of mesalazine-induced cardiotoxicity

Background: Mesalazine is the first-line inflammatory bowel disease (IBD) treatment. However, it can cause fatal cardiotoxicity. We aimed to analyze the clinical characteristics of mesalazine-induced cardiotoxicity and provide evidence for clinical diagnosis, treatment, and prevention.Methods: We co...

Full description

Bibliographic Details
Main Authors: Junyu Chen, Tengfei Duan, Weijin Fang, Shikun Liu, Chunjiang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
mesalazine
cardiotoxicity
inflammatory bowel disease
myocarditis
pericarditis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.970597/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.970597/full

Similar Items